The Centers for Medicare & Medicaid Services (CMS) and other healthcare organizations are aiming to have use of antipsychotics among dementia patients decreased by 30% in the next two years.

CMS said it’s going to keep track of what happens once the antipsychotics will reduced. In addition, CMS will review the cases of residents whose antipsychotics are withdrawn to make sure they don’t suffer an unnecessary decline in functional or cognitive status as a nursing home tries to reduce its usage.

READ FULL ARTICLE Curated publisher From Medical Page Today